Table 1 Preoperative patient data
From: Antimicrobial stewardship measures in cardiac surgery and its impact on surgical site infections
Total | Cefuroxime | Cefazolin | p | |
|---|---|---|---|---|
Patient number (%) | 1029 (100) | 582 (56.6) | 447 (43.4) | |
Sex (%) | ||||
m | 782 (76.0) | 435 (74.7) | 347 (77.6) | 0.283 |
f | 247 (24.0) | 147 (25.3) | 100 (22.4) | |
Age (years) | 68.2 ± 9.86 | 68.0 ± 10.11 | 68.48 ± 9.51 | 0.640 |
BMI (kg/m2) | 28.72 ± 4.73 | 28.90 ± 4.68 | 28.48 ± 4.80 | 0.162 |
Normal weight | 205 (21.3) | 113 (20.7) | 92 (22.0) | |
Overweight | 419 (43.5) | 230 (42.2) | 189 (45.1) | |
BMI Grad (%) Class I Obesity | 247 (25.6) | 149 (27.3) | 98 (23.4) | 0.673 |
Class II Obesity | 72 (7.5) | 40 (7.3) | 32 (7.6) | |
Class III Obesity | 21 (2.2) | 13 (2.4) | 8 (1.9) | |
Creatinine (mg/dL) | 1.32 ± 3.10 | 1.35 ± 4.02 | 1.28 ± 1.07 | 0.037 |
MDRD | 72.0 ± 25.56 | 72.9 ± 24.86 | 70.9 ± 26.43 | 0.092 |
Leucocytes (1/nL) | 8.09 ± 3.90 | 7.93 ± 4.51 | 8.30 ± 2.90 | 0.009 |
CRP (mg/L) | 0.81 ± 2.22 | 0.73 ± 1.73 | 0.92 ± 2.73 | 0.578 |
HbA1c (%) | 6.00 ± 1.00 | 6.01 ± 0.99 | 5.98 ± 1.01 | 0.296 |